HeyJaredFran Lowry
- Indexed articles, last 90 days
- 4
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Bacteriophage Finding Could Help Fight Antibiotic Resistance (opens the original)
Read excerpt
New research has revealed characteristics that make bacteriophages (which are viruses that infect and kill bacteria) more efficient predators. In general, a bacteriophage, or phage, targets just one bacterial strain, but some phages can attack several strains. In the new study, researchers discovered that broader-spectrum phages shared a similar characteristic: particular forms of structural diversity in the fibers on their tails. The discovery could enable the creation of bacteriophage therapie
Decriminalization in BC Fails to Reduce Drug Toxicity Deaths (opens the original)
Read excerpt
A policy of drug decriminalization enacted in British Columbia (BC) between February 2023 and April 2024 resulted in significant reductions in police-recorded drug possession incidents but failed to lower drug toxicity deaths or hospitalizations as BC’s government had hoped. During the province’s partial recriminalization period, from May 2024 to March 2025, police-recorded drug possession incidents rose again. Declines in drug-related hospitalizations occurred during this period of partial recr
SGLT2-GLP-1 Combo Little Better Than Monotherapy in T2D (opens the original)
Read excerpt
With respect to cardiovascular and renal outcomes, combined therapy with SGLT2 inhibitors and GLP-1 receptor agonists has scant benefit compared with using either drug alone in patients with type 2 diabetes, according to a new study. In a meta-analysis of 12 randomized controlled trials that included close to 1 million patients with type 2 diabetes, combined therapy did not significantly reduce the risk for major adverse cardiovascular or kidney events compared with SGLT2 or GLP-1 therapy alone.
Pharmacist-Led Drug Management for HFrEF Cost Effective (opens the original)
Read excerpt
Enlisting pharmacists and nurse practitioners to manage medications for patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) confers health benefits and is cost-effective, according to a simulation model study. “This study found that additional pharmacist- and nurse-practitioner-led medication management in this context can not only save lives and reduce hospitalizations but it can also do so in a way that provides strong value for money,” first author Blair J. MacD
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.